Organoids for Personalised Cancer Medicine
A Vision Assessment of an Emerging Health Technology
Series: SpringerBriefs in Philosophy;
- Publisher's listprice EUR 42.79
-
18 151 Ft (17 287 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 3 630 Ft off)
- Discounted price 14 521 Ft (13 830 Ft + 5% VAT)
18 151 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer
- Date of Publication 12 June 2025
- Number of Volumes 1 pieces, Book
- ISBN 9783031855344
- Binding Paperback
- No. of pages102 pages
- Size 235x155 mm
- Language English
- Illustrations 11 Illustrations, color 700
Categories
Short description:
This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients’ tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored “vision assessment”, presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.
MoreLong description:
This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients’ tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored “vision assessment”, presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.
MoreTable of Contents:
Introduction.- Methodological development.- Vision analysis of patient-derived organoids for personalized cancer medicine.- Vision evaluation of patient-derived organoids in the clinic.- Conclusion.
More
Organoids for Personalised Cancer Medicine: A Vision Assessment of an Emerging Health Technology
Subcribe now and receive a favourable price.
Subscribe
18 151 HUF
